Valganciclovir (Valcyte) is an oral antiviral medication used for cytomegalovirus (CMV) infections. If you're taking it to prevent an infection, you typically take it just once daily. But if you're taking it to treat a CMV infection, you'll likely need to take it twice daily for a few weeks in the beginning of treatment. Some common side effects of valganciclovir (Valcyte) include diarrhea, fever, and fatigue. Valganciclovir (Valcyte) comes as both a tablet and an oral solution, and is available as a lower-cost generic.
Valganciclovir (Valcyte) is metabolized (broken down) by the body to an active antiviral medication called ganciclovir. Ganciclovir stops an enzyme called DNA polymerase. Without this enzyme, the virus can't make copies of itself.
The following side effects may get better over time as your body gets used to the medication. Let your healthcare provider know immediately if you continue to experience these symptoms or if they worsen over time.
Treatment of CMV eye infection:
Prevention of CMV infection after transplant:
Contact your healthcare provider immediately if you experience any of the following.
Side effects that you should report to your care team as soon as possible:
Side effects that usually do not require medical attention (report to your care team if they continue or are bothersome):
No, valganciclovir (Valcyte) isn't an immunosuppressant. This means that valganciclovir (Valcyte) doesn't weaken your immune system. But your provider will most likely prescribed valganciclovir (Valcyte) along with medications that are immunosuppressants after a transplant to prevent a CMV infection.
Your provider will prescribe valganciclovir (Valcyte) after an organ transplant to prevent a CMV infection. CMV is a common virus that can infect people. If you have a healthy immune system, you typically won't experience any symptoms or only mild cold-like symptoms if you have a CMV infection. But if you've had a transplant, your immune system is a lot weaker because of the many of the transplant medications you need to take to prevent an organ rejection. In this case, getting a CMV infection can cause serious health complications for you and raise your risk for losing the transplanted organ.
Your provider will let you know how long you need take valganciclovir (Valcyte) after your organ transplant. The length of valganciclovir (Valcyte) treatment can differ from person to person. Typically, your provider will decide this based on several factors, including results from your blood work and whether you're experiencing any serious side effects from valganciclovir (Valcyte). They'll also take into account your risk of CMV infection, which depends on what kind of transplant you've received. In general, most people take valganciclovir (Valcyte) for 100 to 200 days (about 3 to 6 months) after their transplant because the risk for CMV is highest within the first 3 months after transplant and is lower after 6 months. Don't stop taking valganciclovir (Valcyte) unless your provider instructs you to do so.
No. Both medications are antivirals and their names sound very similar, but they aren't the same. Valganciclovir (Valcyte) is used for the treatment and prevention of CMV. But valacyclovir (Valtrex) is approved to treat herpes virus infections, including cold sores and shingles.
Ask your provider whether you should avoid alcohol or limit how much you drink. Alcohol isn't known to affect how well valganciclovir (Valcyte) works. But it can worsen certain side effects of valganciclovir (Valcyte), like dizziness and confusion. This can be especially dangerous if you're doing a task that requires you to be alert and focused, such as driving. In addition, drinking alcohol might not be safe for you at all if you've recently had a transplant.
Valganciclovir (Valcyte) can cause some serious health issues. This risk may be even higher for certain groups. If this worries you, talk to your doctor or pharmacist about other options.
Valganciclovir (Valcyte) can lower your blood cell counts and damage your bone marrow. This can make it harder for your body to fight new infections and raise your risk of bruising and prolonged bleeding. Your provider will order blood tests regularly and might change your dose of valganciclovir (Valcyte) or stop it altogether if your blood counts become too low. The blood counts typically start to improve 3 to 7 days after stopping the medication.
Let your provider know if you experience any of the following symptoms:
Valganciclovir (Valcyte) at prescribed doses can cause fertility problems in both males and females. Sometimes, this can be permanent. If you're thinking about having a child in the future, talk to your healthcare provider about family planning before you begin treatment.
Valganciclovir (Valcyte) can cause harm to an unborn baby if taken during pregnancy. This harm is also true for males taking the medication who have female partners who can become pregnant. For this reason, females should use an effective birth control method while they are taking valganciclovir (Valcyte) and for at least a month after they stop the medication. Males should use condoms while taking valganciclovir (Valcyte) and for at least 3 months after they stop the medication.
Based on animal studies valganciclovir (Valcyte) has the potential to cause cancer in humans. Make sure to tell your provider about your entire medical history before starting this medication.
Valganciclovir (Valcyte) can cause serious harm to the kidneys, especially in older adults. The risk is also higher if you become dehydrated or take other medications that can harm the kidneys. Stay hydrated while taking valganciclovir (Valcyte) and talk to your provider before taking any medications. Your provider might order regular lab tests to monitor your kidneys. If your labs show changes in your kidney health, your provider may lower your dose of valganciclovir (Valcyte).
Treatment of CMV eye infection
Prevention of CMV infection after transplant
Your dose of valganciclovir (Valcyte) might be different depending on your kidney health.
Contraindications are specific health conditions or situations in which a person should not take a medication due to safety concerns. If you have any of the following conditions or if any of the following apply to you, let your healthcare provider know because Valganciclovir (Valcyte) will not be safe for you to take.